USFDA conducts inspection at Gland Pharma’s API Facility in Visakhapatnam

27 Jan 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at Gland Pharma’s API Facility at JNPC, Visakhapatnam from January 23, 2023 to January 27, 2023 and has been completed with Zero observations.

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1750.55 19.70 (1.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×